Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$895K Buy
4,122
+1,494
+57% +$320K ﹤0.01% 933
2026
Q1
$581K Sell
2,628
-29
-1% -$7.09K ﹤0.01% 832
2025
Q4
$674K Buy
2,657
+117
+5% +$29.4K ﹤0.01% 720
2025
Q3
$629K Buy
2,540
+238
+10% +$57K ﹤0.01% 715
2025
Q2
$553K Buy
2,302
+546
+31% +$127K ﹤0.01% 713
2025
Q1
$398K Buy
1,756
+132
+8% +$29K ﹤0.01% 738
2024
Q4
$334K Sell
1,624
-1,585
-49% -$348K ﹤0.01% 1057
2024
Q3
$778K Buy
+3,209
New +$750K 0.01% 728
2024
Q2
Sell
-964
Closed -$217K 1336
2024
Q1
$217K Buy
+964
New +$217K ﹤0.01% 1006

Other funds holding STE

Savant Capital's STE Position: Q2 2026 in Review

Savant Capital increased its Steris (STE) stake by 57% in Q2 2026, buying an estimated $320K and bringing the position to 4,122 shares worth $895K. The position accounts for ﹤0.01% of the portfolio, ranked #933.

Savant Capital first reported a position in STE in Q1 2024 and has held it in 9 quarters since. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Savant Capital held 4,122 shares of Steris worth $895K as of Q2 2026.
  • Savant Capital bought 1,494 Steris shares in Q2 2026, an estimated $320K.
  • Steris made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #933 holding.
  • Savant Capital first reported a position in Steris in Q1 2024 and has held it in 9 quarters since.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.